Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Inflammatory markers predict cardiovascular risk and mortality in endstage renal disease. The relationship of chronic infections to inflammation and vascular disease events has not been reported among American dialysis patients.
We performed a cross-sectional and prospective study of a multiracial cohort of 97 chronic hemodialysis patients in California. Anti-Chlamydia pneumoniae IgA and IgG antibodies (Cp-IgA and Cp-IgG), anti-Helicobacter pylori antibodies (Hp-IgG), and highly sensitive C-reactive protein (hsCRP) levels were measured at enrollment. We ascertained the prevalence of atherosclerotic vascular (coronary artery, cerebrovascular, and peripheral vascular) disease (AVD) events, and observed participants for at least 1 year for incident events and mortality. We defined statistical significance as P < 0.01.
Elevated hsCRP levels (77%) and seropositivity to C. pneumoniae were common (Cp-IgA, 49%; Cp-IgG, 64%), whereas the seroprevalence of Hp-IgG was relatively low (25%). The hsCRP levels did not vary with infection status. In bivariate analysis, Cp-IgA and Cp-IgG were each associated with approximately fourfold higher odds of prevalent AVD (P < 0.01). Although anti-chlamydial antibodies maintained nearly significant associations with AVD after covariate adjustment (P < 0.05), antibodies did not predict outcomes over the period of observation. However, hsCRP was a nearly significant independent predictor of prevalent AVD (P = 0.02) and of mortality during follow-up (P = 0.01). We did not detect an association of Hp-IgG with any study outcome.
Our findings generalize a possible link between C. pneumoniae and prevalent atherosclerosis in American hemodialysis patients and confirm the importance of hsCRP as a prognostic indicator. Our work does not support H. pylori as an important mediator of cardiovascular risk in dialysis patients.
- Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients
Clinical and Experimental Nephrology
Volume 10, Issue 1 , pp 55-62
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Cardiovascular disease
- Chlamydia pneumoniae
- C-reactive protein
- Helicobacter pylori
- Industry Sectors
- Author Affiliations
- A1. Saint Louis University Center for Outcomes Research Salus Center, 2nd Floor, 3545 Lafayette Avenue, St. Louis, MO, 63104, USA
- A2. Division of Nephrology, Department of Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA
- A3. Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
- A4. Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA
- A5. Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
- A6. Diablo Nephrology Medical Group, Walnut Creek, CA, USA